Abstract : The lysosomal protease cathepsin D is associated with tumor progression in malignant tumors, but its presence in pre-malignant dysplastic cells has not been established. The purpose of this study is to evaluate the expression patterns of the cathepsin D, Ki-67, and p53 proteins in dysplastic cells in uterine cervical intraepithelial neoplasias (CINs). In 52 patients with uterine CINs, expression of the cathepsin D, Ki-67, and p53 proteins was assessed in dysplastic cells by immunohistochemistry with monoclonal antibodies against cathepsin D, Ki-67, and p53. Immunohistochemical analysis revealed high levels of cathepsin D (>10% cathepsin D-positive dysplastic cells) in 3 of 17 cervical intraepithelial neoplasia (CIN) 1 specimens, 16 of 20 CIN2 specimens, and in all 15 CIN3 specimens. Cathepsin D expression was significantly higher in CIN2 and CIN3 specimens than in CIN1 specimens (P < 0.01). but did not differ significantly between CIN2 and CIN3 specimens. The proportion of dysplastic cells that expressed nuclear Ki-67 was 26.41% in CIN1 specimens, 50.35% in CIN2 specimens, and 76.33% in CIN3 specimens. Ki-67-positive dysplastic cells were significantly increased in CIN2 and CIN3 specimens as compared to CIN1 specimens (P < 0.01), and in CIN3 specimens as compared to CIN2 specimens (P < 0.01). High expression of nuclear p53 (>10% p53-positive dysplastic cells) was detected in 4 of 17 CIN1 specimens, 12 of 20 CIN2 specimens, and in 11 of 15 CIN3 specimens. Nuclear p53 expression was significantly higher in CIN2 and CIN3 specimens than in CIN1 specimens (P < 0.01), but did not differ significantly between CIN2 and CIN3 specimens. Compared to dysplastic cells in CIN1, dysplastic cells in CIN2 have an increased invasive growth potential, as shown by their increased expression of cathepsin D, a higher proliferating potential as shown by their increased expression of Ki-67, and a higher p53 expression.
. Cases with more than 10% of dysplastic cells showing strong nuclear reactivity for p53 were classified as p53-positive 11) Statistical analysis Chi-squared test and Fisher's exact probability test were used to compare frequencies.
Results

Cathepsin D in uterine CIN
Cathepsin D staining had a fine granular appearance and was localized to the cytoplasm of dysplastic cells in CIN ; cathepsin D expression was not detected in normal cervical squamous epithelium adjacent to the CIN. Three of the 17 CINI specimens (Fig. lb) , 16 of the 20 CIN2 specimens (Fig. 2b) , and all 15 CIN3 specimens (Fig. 3b) were cathepsin D-positive (Table 1 ). There were significantly more cathepsin D-positive CIN2 and CIN3 specimens than CINI specimens (P < 0.01), but the incidence was not significantly different between CIN2 and CIN3 (Table 1) . Ki p53 in uterine GIN p53 staining was localized to the nuclei of dysplastic cells in CINI, CIN2, and CIN3. A weak p53 expression was detected in normal squamous epithelium adjacent to CINs, but positive cells accounted for less than 10%. Four of the 17 CINI specimens (Fig, id) , 12 of the 20 CIN2 specimens (Fig. 2d) and 11 of the 15 CIN3 specimens (Fig. 3d) were p53-positive (Table 1) . p53 expression was significantly higher in CIN2 and CIN3 than in CINI (P < 0.01), but there was no statistical difference between CIN2 and CIN3 ( 2). In CIN2, the Ki-67 labeling index of cathepsin D-positive specimens (49.81±19.79%) was not significantly different from that of cathepsin D-negative specimens (52.5 ± 8.29%) ( Table 2 ). All CIN3 specimens were cathepsin D-positive (Table 2) .
Correlation between cathepsin D and nuclear p53 accumulation in dysplastic cells In CIN1, none of the 3 cathepsin D-positive specimens was p53-positive, whereas 4 of the 14 cathepsin D-negative specimens were p53-positive (Table 2) . This difference was not statistically significant. In CIN2, 12 of the 16 cathepsin D-positive specimens were p53-positive, whereas none of the 4 cathepsin D-negative specimens was p53-positive (Table 2) . This difference was statistically significant (P < 0.01). All CIN3 specimens were cathepsin D-positive ( 
